Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Site Reference ID/Investigator# 26350, Caracas

Site Reference ID/Investigator# 44206, Caracas

Site Reference ID/Investigator# 44203, Caracas

Site Reference ID/Investigator# 44204, Estado Carabobo

Site Reference ID/Investigator# 44202, Bolívar

Site Reference ID/Investigator# 42109, Mexico City DF

Site Reference ID/Investigator# 42104, Tijuana, Baja California Norte

Site Reference ID/Investigator# 42106, Mexico City DF

Site Reference ID/Investigator# 42108, Aguascalientes

Site Reference ID/Investigator# 42110, Aguascalientes

Site Reference ID/Investigator# 42112, Tijuana, Baja California Norte

Site Reference ID/Investigator# 42111, Tuxtla Gutierrez, Chiapas

Site Reference ID/Investigator# 42114, Tuxtla Gutierrez, Chiapas

Site Reference ID/Investigator# 42103, Guadalajara, Jalisco

Site Reference ID/Investigator# 42115, Zapopan, Jalisco

Site Reference ID/Investigator# 42105, Metepec, Estado de Mexico

Site Reference ID/Investigator# 42113, Zacatecas City

Site Reference ID/Investigator# 48183, Santiago de Cali

Site Reference ID/Investigator# 48182, Santiago de Cali

Site Reference ID/Investigator# 26348, Mexico City

Site Reference ID/Investigator# 42102, Mexico City DF

Site Reference ID/Investigator# 42107, Mexico City DF